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Introduction: Large-volume cold intravenous infusion of crystalloids has been used for induction of therapeutic
hypothermia after cardiac arrest. However, the effectiveness of cold colloids has not been evaluated. Therefore, we
performed an experimental study to investigate the cooling effect of cold normal saline compared to colloid
solution in a porcine model of ventricular fibrillation.
Methods: Ventricular fibrillation was induced for 15 minutes in 22 anesthetized domestic pigs. After spontaneous
circulation was restored, the animals were randomized to receive either 45 ml/kg of 1°C cold normal saline (Group A,
9 animals); or 45 ml/kg of 1°C cold colloid solution (Voluven®, 6% hydroxyethyl starch 130/0.4 in 0.9% NaCl) during
20 minutes (Group B, 9 animals); or to undergo no cooling intervention (Group C, 4 animals). Then, the animals were
observed for 90 minutes. Cerebral, rectal, intramuscular, pulmonary artery, and subcutaneous fat body temperatures
(BT) were recorded. In the mechanical ex-vivo sub study we added a same amount of cold normal saline or colloid
into the bath of normal saline and calculated the area under the curve (AUC) for induced temperature changes.
Results: Animals treated with cold fluids achieved a significant decrease of BT at all measurement sites, whereas there
was a consistent significant spontaneous increase in group C. At the time of completion of infusion, greater decrease
in pulmonary artery BT and cerebral BT in group A compared to group B was detected (−2.1 ± 0.3 vs. -1.6 ± 0.2°C,
and −1.7 ± 0.4 vs. -1.1 ± 0.3°C, p < 0.05, respectively). AUC analysis of the decrease of cerebral BT revealed a more
vigorous cooling effect in group A compared to group B (−91 ± 22 vs. -68 ± 23°C/min, p = 0.046). In the mechanical
sub study, AUC analysis of the induced temperature decrease of cooled solution revealed that addition of normal
saline led to more intense cooling than colloid solution (−7155 ± 647 vs. -5733 ± 636°C/min, p = 0.008).
Conclusions: Intravenous infusion of cold normal saline resulted in more intense decrease of cerebral and pulmonary
artery BT than colloid infusion in this porcine model of cardiac arrest. This difference is at least partially related to the
various specific heat capacities of the coolants.Introduction
The technique of large-volume cold intravenous infusion
has been found to be a simple, efficient and safe method
of inducing therapeutic hypothermia (TH) in cardiac ar-
rest survivors [1,2], therefore, it has been widely adopted
[1,3]. However, in many patients, it fails to achieve target* Correspondence: skulec@email.cz
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reproduction in any medium, provided the orbody temperature of 34°C [1,4-9]. Several conditions
may have an impact on cooling efficiency, indicating that
there is room for optimization of the cooling protocol
[10]. One of the potential approaches to improve cooling
efficacy is to search for the most efficient coolant. Differ-
ent solutions may exert different cooling effects based
on their particular specific heat capacity and their im-
pact on hemodynamics and heat exchange in the body.
However, there is a lack of the knowledge on this
specific topic. Therefore, we have carried out an experi-
mental study to investigate the cooling effect of rapid
intravenous infusion of cold normal saline compared toLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ventricular fibrillation (VF). We hypothesized that equiva-
lent volumes of those types of fluids may cause a different
decrease in body temperature (BT).
Materials and methods
We performed a prospective randomized controlled ex-
perimental study on 22 healthy female domestic pigs
(Sus scrofa f. domestica) weighing 30 to 35 kg (mean 33 ±
SD 2 kg). The experiment was performed in the Animal
Research Laboratory of the University of Defence, Faculty
of Military Health Sciences, Czech Republic. The study
protocol was approved by the Animal Investigation
Committee of the University of Defence Brno, Faculty of
Military Health Sciences Hradec Kralove, Czech Republic
and the Departmental Commission for the Protection
of Animals of the Ministry of Defence, Prague, Czech
Republic. All experimental animals received humane care
in compliance with the institutional guidelines. Animals
were fasted overnight, but had free access to water.
Anesthesia was used in all surgical interventions. We also
performed a mechanical substudy without any involve-
ment of humans or experimental animals in the setting of
air-conditioned laboratory conditions.
Animal preparation
The animals were premedicated by intramuscular injec-
tion of azaperone (2.0 mg/kg), atropine (0.2 mg/kg) and
ketamine (20.0 mg/kg) 30 minutes before surgery. This
was followed by ear-vein injection of thiopental (3 mg/kg).
The pigs were fixed in the right lateral position on the
backboard of the resuscitation system AutoPulse Model
100 (Zoll, Medical Corp. Chelmsford, MA, USA), intubated
and mechanically ventilated (Siemens-Elema SV 900C, AB,
Solna, Sweden) at 19 breaths/minute, and inspired oxygen
fraction (FiO2) of 0.4. Tidal volumes were adjusted to
maintain end-tidal CO2 at 35 to 45 mm Hg. Anesthesia
and muscle paralysis were maintained with a continuous
infusion of midazolam (0.3 mg/kg/h), fentanyl (5 to 20 μg/
kg/h) and pancuronium (0.5 mg/kg/h). In addition to inter-
ventions in groups A and B, all animals were continuously
given normal saline (B. Braun, Melsungen, Germany) at
room temperature (50 ml/h). Vital signs were continuously
monitored with two Datex-Ohmeda Type S/5 monitors
(Datex-Ohmeda Instrumentarium Corp., Helsinki, Finland)
and a Zoll M Series defibrillator (Zoll Medical Corp.). The
distinct infusion rate of coolants was controlled by a Power
Infuser (Zoll Medical Corp.).
Measurements
After induction of anesthesia, the thoracic aorta was can-
nulated via the carotid artery with a 7F 200-mm catheter
Certofix Duo (B. Braun) for monitoring of aortic blood
pressure. An 8.5F percutaneous sheath introducer Intro-Flex (Edwards Lifesciences LLC, Irvine, CA, USA) was
inserted via the internal jugular vein into the superior
vena cava to enable insertion of a CCOmbo Volumetrics
Pulmonary Artery Catheter (Edwards Lifesciences LLC)
for continual monitoring of pulmonary artery BT, right
atrial pressure, pulmonary artery pressure, cardiac index,
mixed venous oxygen saturation and intermittent meas-
urement of pulmonary artery wedge pressure. A 5-mm
diameter burr-hole craniotomy at the upper part of the
frontal bone was created on the left side to insert an intra-
cranial pressure monitoring device. A parenchymal probe
Codman MicroSensor ICP Transducer (Codman, Johnson
& Johnson, Raynham, MA, USA) was inserted 20 mm
into the frontal lobe. Cerebral, rectal, intramuscular,
and subcutaneous fat BT were continuously recorded
using GMH 3250 digital thermometers (Greisinger
Electronic, Regenstauf, Germany). A cerebral probe was
placed 20 mm into the right hemisphere, on the opposite
site of the head from the intracranial pressure probe.
Intramuscular and subcutaneous fat BT probes were
inserted into the right gluteal muscle and abdominal sub-
cutaneous adipose tissue, respectively. Coronary perfusion
pressure (CoPP) was defined as the pressure difference be-
tween diastolic aortic pressure and right atrial pressure
during the decompression phase. Cerebral perfusion pres-
sure (CPP) was calculated from mean aortic pressure
(MAP) and intracranial (ICP) or central venous pressure
(CVP) according to the formula:
CPP ¼ MAP–ICP if ICP ≥ CVP or
CPP ¼ MAP–CVP if CVP > ICP:
Experimental protocol
Figure 1 outlines the protocol flow chart. After animal
preparation and stabilization, ventricular fibrillation (VF)
was induced with an alternating current of 5 to 10 V
using an intra-cardiac bipolar pacing lead introduced
into the right ventricle. Cardiac arrest was confirmed as
the time point at which aortic pressures dropped down
to equal values and the electrocardiogram (ECG) showed
VF. The animals were left in non-resuscitated cardiac ar-
rest for 5 minutes. Thereafter, mechanical chest com-
pressions at a rate of 100/minute without ventilation
were performed for 5 minutes using the AutoPulse.
Mechanical ventilation (10 breaths/minute, FiO2 = 1.0,
tidal volume 8 ml/kg) was then added. Fifteen minutes
after induction of cardiac arrest, a defibrillation shock of
150 J was delivered to restore spontaneous circulation,
and repeated if necessary. When return of spontaneous
circulation (ROSC) was reached, chest compressions were
terminated and ventilatory support was set to the baseline
regimen. Thereafter, the pigs were randomly assigned into
three groups to receive either 45 ml/kg of 1°C cold normal
Figure 1 Flow chart of the animal experimental protocol. CPR, cardiopulmonary resuscitation; ROSC, return of spontaneous circulation;
NS, normal saline.
Table 1 Selected values of physiological variables







Body weight (kg) - - -
BSA (m2) - - -
Pulmonary artery
BT (mm Hg)
36.7 ± 0.4 36.6 ± 0.9 36.7 ± 0.9
Cerebral BT (°C) 36.8 ± 0.5 36.8 ± 0.8 36.9 ± 1.0
Rectal BT (°C) 36.6 ± 0.4 36.8 ± 0.9 36.7 ± 0.4
Intramuscular BT (°C) 36.7 ± 0.4 36.8 ± 0.9 36.7 ± 1.0
Subcutaneous fat
BT (°C)
36.4 ± 0.5 36.6 ± 1.0 36.6 ± 0.9
Cardiac index
(l/minute/m2)
7.8 ± 1.4 7.4 ± 1.5 7.6 ± 0.5
Intracranial pressure
(mm Hg)
11 ± 7 12 ± 6 11 ± 1
Coronary perfusion
pressure (mm Hg)
55 ± 20 56 ± 16 56 ± 16
Cerebral perfusion
pressure (mm Hg)
62 ± 18 63 ± 17 63 ± 19
P >0.05 for all differences between the groups. BSA, body surface area;
BT, body temperature.
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45 ml/kg of 1°C cold colloid solution (Voluven®, 6%
hydroxyethyl starch 130/0.4 in normal saline, Fresenius
Kabi AG, Bad Homburg, Germany) during 20 minutes
(Group B, nine animals); or to serve as a control group
with no cooling intervention (Group C, four animals).
During the subsequent 90 minutes, the animals were
observed to assess the effect of interventions on BT and
hemodynamics. After this period, the animals were
sacrificed in deep anesthesia by re-induction of VF, and
autopsied.
The aim of the mechanical substudy was to compare
the specific heat capacities (SHC) of the coolants used in
groups A and B. Normal saline (500 ml) was prepared in
a beaker to serve as the experimental cooled solution.
After we achieved temperature equilibrium, we poured
into the solution 50 ml of 1°C cold normal saline or 50 ml
of 1°C cold colloid solution in random order. We
proceeded with continuous temperature monitoring of
the cooled solution for 120 minutes. Afterwards, we calcu-
lated the area under the curve (AUC) for temperature
changes. For each coolant, five sessions were repeated and
averaged for further analysis.
Statistical analysis
For the statistical analysis, measurements were taken at
the baseline, immediately before cold infusion (10 minutes
after ROSC), 10 minutes after the start of cold infusion,
after finishing cold infusion, and every 10 minutes during
the period of observation until the end of the animal ex-
perimental protocol. At every defined time point, we cal-
culated the difference between the actual BT and the BT
immediately before cold infusion, for comparison between
the groups. In the mechanical substudy, we sampled the
temperature of the cooled solution every 20 seconds dur-
ing 120 minutes of monitoring. For every time point we
calculated the difference between the baseline and actual
temperature. The AUC from the differences was calcu-
lated by a trapezoid rule. Mean values ± SD or percentages
were calculated as necessary. Differences between groups
were compared using the χ2 test, and statistical signifi-
cance was calculated by the Fischer exact test for alterna-
tive variables. Statistical significance for continuousvariables was determined by the paired Student t-test.
Data were analyzed using Microsoft Excel 2007 and JMP
3.2 statistical software. A P-value of <0.05 was considered
statistically significant.
Results
There were no significant differences in any physiological
variables between the baseline values and values immedi-
ately before cold infusion among the three experimental
groups (Table 1). The groups were comparable in the
number of defibrillation shocks delivered (group A, 1.7 ±
1.0; group B, 1.7 ± 0.7; group C, 1.5 ± 0.6; P = 0.936) and in
time from induction of VF to ROSC (group A, 16.3 ± 2.0;
group B, 16.3 ± 1.4; group C, 16.0 ± 1.1; P = 0.936). The
animals treated with cold fluids achieved a significant
decrease in BT at all measurement sites, whereas there
was a consistent spontaneous increase in group C. The
differences between the change in BT in group C and
groups A or B were significant at all sites at all phases
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90 minutes of further monitoring. (Figure 2, Table 2). At
the time of completion of the infusion, a significantly
greater decrease in pulmonary artery BT and cerebral BT in
group A compared to group B was detected (−2.1 ± 0.3 ver-
sus −1.6 ± 0.2°C, and −1.7 ± 0.4 versus −1.1 ± 0.3°C, P <0.05
respectively) (Figure 2). We did not observe any significant
differences in the changes in rectal, intramuscular and
subcutaneous fat BT between groups A and B (Table 2).
Maximal decrease in BT was recorded at all sites of meas-
urement on completion of the infusion or 10 minutes after
finishing the infusion in groups A and B. Although consid-
erable and ongoing re-warming was observed at the pul-
monary artery, cerebral, rectal and intramuscular BT
measurement sites soon after finishing the infusion untilFigure 2 Course of changes in arteria pulmonalis and cerebral body tem
body temperature (BT). (B) Cerebral BT. Solid line, group A; dotted line, groupthe end of the protocol, a more intense and persistent de-
crease in the temperature of subcutaneous fat was revealed
at these compared to other sites in groups A and B from 20
minutes after the finishing infusion (Table 2).
AUC analysis of the decrease in cerebral BT revealed a
more vigorous cooling effect in group A compared to
group B (−91 ± 22 versus −68 ± 23°C/minute, P = 0.046).
Figure 3 demonstrates the hemodynamic effect of in-
terventions in groups A and B. For group C animals,
Figure 2 shows a spontaneous temporary decrease in
CPP and CoPP followed by progressive increase above
baseline values. Rapid infusion of cold normal saline in
group A significantly precipitated CoPP restoration and
the same trend was identified in group B. The impact of
cold infusion on CPP was found similar to that on CoPP.perature during the protocol in all groups. (A) Arteria pulmonalis
B; dashed line, group C.
Table 2 Time course of rectal, intramuscular and subcutaneous fat body temperature changes from before infusion
until the end of the protocol
Time point Rectal BT Intramuscular BT Subcutaneous fat BT
Group A Group B Group C Group A Group B Group C Group A Group B Group C
During infusion −0.4 ± 0.2 −0.4 ± 0.3 0.2 ± 0.1a −0.6 ± 0.2 −0.5 ± 0.2 0.2 ± 0.2a −0.7 ± 0.4 −0.5 ± 0.2 0.3 ± 0.1a
End of infusion −1.2 ± 0.4 −1.1 ± 0.4 0.4 ± 0.2a −1.5 ± 0.3 −1.2 ± 0.3 0.3 ± 0.1a −1.6 ± 0.5 −1.3 ± 0.3 0.5 ± 0.2a
10 minutes −1.4 ± 0.3 −1.2 ± 0.3 0.6 ± 0.2a −1.4 ± 0.4 −1.2 ± 0.3 0.4 ± 0.3a −1.7 ± 0.5 −1.5 ± 0.3 0.6 ± 0.2a
20 minutes −1.3 ± 0.3 −1.2 ± 0.3 0.7 ± 0.2a −1.2 ± 0.4 −1.1 ± 0.4 0.6 ± 0.3a −1.6 ± 0.5 −1.6 ± 0.3c 0.8 ± 0.2a
30 minutes −1.1 ± 0.4 −1.1 ± 0.4 0.9 ± 0.2a −1.0 ± 0.4 −1.0 ± 0.4 0.7 ± 0.4a −1.4 ± 0.4 −1.6 ± 0.4c 1.0 ± 0.4a
40 minutes −1.0 ± 0.4 −1.0 ± 0.4 1.0 ± 0.3a −0.9 ± 0.4 −0.9 ± 0.5 1.1 ± 0.2a −1.3 ± 0.5 −1.6 ± 0.4c 1.2 ± 0.3a
50 minutes −0.9 ± 0.4 −0.9 ± 0.4 1.1 ± 0.3a −0.8 ± 0.4 −0.8 ± 0.5 1.1 ± 0.5a −1.2 ± 0.4 −1.4 ± 0.5c 1.4 ± 0.4a
60 minutes −0.9 ± 0.4 −0.9 ± 0.5 1.3 ± 0.3a −0.7 ± 0.4 −0.7 ± 0.6 1.2 ± 0.6a −1.1 ± 0.4 −1.5 ± 0.6c 1.6 ± 0.5a
70 minutes −0.7 ± 0.4 −0.7 ± 0.6 1.4 ± 0.3a −0.6 ± 0.4 −0.6 ± 0.6 1.3 ± 0.6a −1.1 ± 0.4b −1.4 ± 0.6c 1.7 ± 0.5a
80 minutes −0.6 ± 0.5 −0.6 ± 0.6 1.5 ± 0.3a −0.5 ± 0.4 −0.5 ± 0.7 1.4 ± 0.7a −1.0 ± 0.4b −1.3 ± 0.6c 1.8 ± 0.4a
90 minutes −0.6 ± 0.5 −0.6 ± 0.6 1.4 ± 0.3a −0.6 ± 0.4 −0.4 ± 0.8 1.4 ± 0.6a −1.0 ± 0.4b −1.2 ± 0.6c 1.8 ± 0.4a
Results are presented as mean ± SD. aSignificant difference between group C and groups A and B at each site of measurement; bsignificant difference between
subcutaneous fat body temperature (BT) changes in group A and group B temperature changes at all other measurement sites; csignificant difference between
subcutaneous fat BT changes in group B and group B temperature changes at all other measurement sites.
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lution led to a vigorous increase in ICP during the infu-
sion and up to 30 minutes after its administration,
whereas the ICP profile in group A traced the group C
pattern (Figure 3). The cardiac index continuously de-
creased in group C until the end of the protocol. Cold
infusion in both interventional groups induced a signifi-
cant increase in the cardiac index, more intense in group
B than A, with the maximum in the thirtieth minute
after finishing the infusion (group A, 9.0 ± 1.4; group B,
10.4 ± 2.1; group C, 7.0 ± 0.2; P <0.05). This was followed
by a subsequent decrease to baseline values at the end of
the protocol (group A, 8.0 ± 1.5; group B, 8.4 ± 1.5;
group C, 6.1 ± 0.9; P = 0.05).
In the mechanical substudy, AUC analysis of the induced
decrease in cooled solution temperature revealed signifi-
cant differences between the coolants. Addition of normal
saline led to more intense cooling than colloid solution
(−7155 ± 647 versus −5733 ± 636°C/minute, P = 0.008).
Discussion
The main finding of the present study is that in this
model a large volume of cold intravenous infusion of
normal saline results in a more intense decrease in
cerebral BT than colloid infusion. The method of
intravenous cooling has been found efficient and safe.
Infusion of 15 to 30 ml/kg of 4°C cold crystalloid at
an infusion rate >60 ml/h may induce a decrease in
BT >1.4°C [4-9]. However, there is significant inter-
individual variability of cooling efficiency. Even adminis-
tration of up to 30 ml/kg of cold fluid ensures the target
therapeutic temperature of ≤34.0°C in fewer than 50% of
patients [4,8,10]. There are several circumstances that
may influence the cooling efficacy: inaccurate techniquefor BT measurement, under-dosing of the cold infusion,
re-warming of coolant during its administration, type of
intravenous access, cooling responsiveness of the patient
and the type of coolant [10].
In theory, cooling efficacy of a coolant per se can
be determined in two ways. First, there are different
chemical and physical properties primarily expressed
by different SHC of the coolant. Second, different
chemical composition may influence thermoregulatory
processes in the organism by affecting thermal ex-
change effectiveness, just as different fluids have a
different impact on hemodynamics. In the presented
pilot study, we focused on the comparison of cooling
efficacy of both coolants, and we attempted to assess
whether any potential difference may be affected by
different SHC.
Vanden Hoek et al. compared the cooling effect of
microparticulate saline slurry (MPS) versus chilled saline
administered in 11 anesthetized farm swine with intact cir-
culation [11]. MPS administration was associated with
considerably greater decrease in cortical brain temperature
than an equal amount of cold normal saline (5.3 ± 0.7 ver-
sus 3.4 ± 0.4°C, P = 0.009). MPS represents a potential so-
lution designed for more efficient cooling. However, it is
not manufactured and not available on the market. The
authors also have presented an excellent model of heat
content calculation for normal saline and MPS. Consist-
ently with other results, it was higher for MPS than for
normal saline. Although the model includes several ap-
proximations (specific heat of the body, virtual presump-
tion of proportional distribution of the coolant in the
body, ice load estimation in MPS), which may bring un-
certainty into interpretation of the results, it represents a
valid model for conducting further research.
Figure 3 Values of coronary perfusion pressure (CoPP), cerebral perfusion pressure (CPP) and intracranial pressure (ICP) during the
protocol. (A) CoPP values. (B) CPP and ICP values. Asteriks indicate significant differences between group C and group A and/or B. Solid line,
group A; dotted line, group B; dashed line, group C. Solid square symbols indicate significant differences between group A and group B. ROSC,
return of spontaneous circulation.
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tal study evaluating the cerebral and hemodynamic con-
sequences of intravenous infusion of different volumes of
cold Ringer’s solution or cold hypertonic hyperoncotic so-
lution for induction of TH in a pig model of resuscitated
cardiac arrest [12]. The animals were randomized to re-
ceive either 30 ml/kg administration of 4°C cold acetated
Ringer’s solution (M group, n = 10) or 3 ml/kg of 4°C of
hypertonic saline 7.5% - dextran 6% solution (L group,
n = 10) during 30 minutes. Although administration of
colloid solution was associated with greater reduction
in cerebral edema than crystalloid infusion, the M
group animals exhibited less neuronal damage than
those in the L group. Thus, these observations remain
inconclusive as to whether one of the treatments ex-
hibits a clear neuroprotective effect. Even though the
median time to target pulmonary artery temperature of
34°C was comparable in both groups (M group, 48.8 ±
8.6 minutes; L group, 51.5 ± 7.8 minutes; P >0.05), from
the physical point of view this cannot be an expression
of 10-fold higher cooling effectiveness of colloid com-
pared to Ringer’s solution, and there is no doubt that
additional external cooling via ice packs played a role.
In our experiment, a more intense decrease in cerebral
and pulmonary artery BT at the time point of the end of
the infusion was found in the group with normal saline,
and the AUC for the cerebral BT decrease throughout
the complete protocol indicated a more pronounced
cooling effect of normal saline than of colloid solution.
The question is what the major mechanism of this dif-
ference is.
SHC is the amount of heat per unit mass required to
raise the temperature by one degree Celsius. In the clin-
ical setting of TH induced by cold infusion, it means
that the higher the SHC of the coolant, the more heat
must be expended by the body to re-warm itself, which
is an expression of more intense cooling efficacy. It is
known that water has a high SHC of 4180 J/kg/°C, due
to which it is used as an effective coolant in industry. Sa-
line solution has a lower SHC, which decreases with the
concentration of NaCl [13]. Blake et al. referred to the
SHC of gelofusine as 4082 j/kg/°C [14]. Nevertheless,
the SHC of novel colloid solutions has never been pub-
lished. In our mechanical substudy, we did not measure
absolute SHC values, but instead calculated the AUC of
temperature changes for both coolants, a reflection of
their relative SHC. As expected, we found this lower for
colloid solution than for normal saline, and the differ-
ence appears clinically relevant. Thus, normal saline of-
fers an advantage over an isotonic iso-oncotic solution
of hydroxyethylamylum in normal saline in terms of
physical and chemical properties directly related to
cooling. Extrapolated to our animal experiment, it is
thus reliable that the chemical composition of theinvestigated coolants is responsible for observed differ-
ences in cooling effect in vivo.
With respect to the impact of the investigated fluids
on the process of thermal exchange within the body, it is
not possible to draw any conclusions. We observed no
relevant differences in hemodynamic variables through-
out the protocol, and this will be the subject of further
experiments. Other aspects to consider are whether
intervention with different coolants may produce any
adverse effects. After the cooling procedure, we did not
observe any arrhythmia or signs of pulmonary edema.
No unintentional cardiac arrest and no post-cardiac ar-
rest shock syndrome developed in any animal after the
ROSC. Massive volume-expansion in groups A and B
had an impact on CPP and CoPP. Although in both
groups we observed swifter restoration to the baseline
values than in group C, colloid solution induced a dis-
tinct rise in ICP, which may be deleterious and disquali-
fying for clinical application. It is true that in our
experiment we administered extreme doses of cold fluids
at high infusion rate, supranormal to clinical dosage.
However, significant ICP increase was already observed
halfway through the intravenous cooling, which is
equivalent to an application of 20 to 25 ml/kg. Expect-
edly, both colloid and crystalloid infusions induced an
increase in the cardiac index [15].
There are some other limitations of our study, especially
when considering its potential introduction into human
medicine. We did not evaluate the impact of the interven-
tion on neuronal damage, and we did not investigate
whether the same amount of normal saline and colloid so-
lution at room temperature has the same hemodynamic
consequences as the cold solutions, performing the pilot
study. The experiment was performed on animals without
any evidence of heart disease before cardiac arrest, the
dose of administered coolant was far beyond the thera-
peutic scope, and in general colloid infusion should be
stored and used at room temperature.
However, we did not detect any apparent evidence of
benefit of cold colloid infusion, and we should also be
aware of known adverse events of colloid infusion, such
as coagulopathy and the risk of renal injury in the clin-
ical setting of post-cardiac arrest shock syndrome. More-
over, colloids are more expensive than crystalloids.
Conclusions
In conclusion, large-volume cold intravenous infusion of
normal saline resulted in more intense decrease in cere-
bral and pulmonary artery BT than colloid infusion of
the same temperature and volume in this model of car-
diac arrest. This difference is at least partially related to
the various SHC of the coolants. Whether the different
cooling effects of coolants may also be mediated through
their different impact on thermoregulatory processes in
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ministration of colloid infusion was associated with tem-
porary unacceptable increase in intracranial pressure.
Considering other known adverse effects of high doses
of colloids, we cannot recommend their regular use for
induction of TH.
Key messages
 Large-volume intravenous infusion of cold normal
saline resulted in more intense decrease of cerebral
and pulmonary artery body temperature than colloid
infusion in this porcine model of cardiac arrest
 This difference is at least partially related to the
various specific heat capacities of the coolants.
 Administration of colloid infusion was associated
with temporary unacceptable increase of intracranial
pressure.
 Considering the points above, we cannot
recommend their regular use for induction of
therapeutic hypothermia.
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